How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

6,129 results for

Depression Screening Tools

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

241. Self-reported depression symptoms in haemodialysis patients: Bi-factor structures of two common measures and their association with clinical factors. Full Text available with Trip Pro

Self-reported depression symptoms in haemodialysis patients: Bi-factor structures of two common measures and their association with clinical factors. To validate the factor structure of two common self-report depression tools in a large sample of haemodialysis (HD) patients and to examine their demographic and clinical correlates, including urine output, history of depression and transplantation.Factor structures of the Beck Depression Inventory (BDI-II) and Patient Health Questionnaire (PHQ-9 (...) ) were evaluated using confirmatory factor analysis (CFA). Data was utilised from the screening phase (n = 709) of a placebo-controlled feasibility randomised control trial (RCT) of sertraline in HD patients with mild to moderate Major Depressive Disorder. Alternative factor models including bi-factor models for the BDI-II and PHQ-9 were evaluated. Coefficient omega and omega-hierarchical were calculated.For both measures, bi-factor measurement models had the overall best fit to the data

2019 General hospital psychiatry Controlled trial quality: uncertain

242. Use of machine learning in predicting clinical response to transcranial magnetic stimulation in comorbid posttraumatic stress disorder and major depression: A resting state electroencephalography study. (Abstract)

with high specificity, and identified pre- and post-TMS status using EEG coherence. This approach may provide mechanistic insights and may also become a clinically useful screening tool for TMS candidates.Copyright © 2019. Published by Elsevier B.V. (...) Use of machine learning in predicting clinical response to transcranial magnetic stimulation in comorbid posttraumatic stress disorder and major depression: A resting state electroencephalography study. Repetitive transcranial magnetic stimulation (TMS) is clinically effective for major depressive disorder (MDD) and investigational for other conditions including posttraumatic stress disorder (PTSD). Understanding the mechanisms of TMS action and developing biomarkers predicting response remain

2019 Journal of Affective Disorders

243. Identification of Anxiety and Depression Symptoms in Patients With Cancer: Comparison Between Short and Long Web-Based Questionnaires. Full Text available with Trip Pro

with anxiety symptoms with high accuracy. For HADS depression, at a cutoff of >5 and eVAS depression at a cutoff of >7 hs, the accuracy was very high likewise.The use of the short and ultrashort tools, eVAS and HADS, may be a suitable initial method of Web-based screening in busy clinical settings. However, there are still a proportion of patients who lack access to the internet or the ability to use it. There is a need to find solutions for this group to find all the patients with psychological distress.© (...) Identification of Anxiety and Depression Symptoms in Patients With Cancer: Comparison Between Short and Long Web-Based Questionnaires. Physicians and nurses in cancer care easily fail to detect symptoms of psychological distress because of barriers such as lack of time, training on screening methods, and knowledge about how to diagnose anxiety and depression. National guidelines in several countries recommend routine screening for emotional distress in patients with cancer, but in many clinics

2019 Journal of medical Internet research

244. Extent and Predictors of Potentially Inappropriate Antidepressant Use Among Older Adults With Dementia and Major Depressive Disorder. (Abstract)

Effectiveness Data and Information Set guidelines, intake period for new antidepressant medication use was from May 1, 2012, through April 30, 2013. Index prescription start date was the first date of antidepressant prescription claim during the intake period. Dependent variable of this study was potentially inappropriate antidepressant use as defined by the Beers Criteria and the Screening Tool of Older Persons' potentially inappropriate Prescriptions criteria. The authors conducted multiple logistic (...) Extent and Predictors of Potentially Inappropriate Antidepressant Use Among Older Adults With Dementia and Major Depressive Disorder. To quantify the extent and identify predictors of potentially inappropriate antidepressant use among older adults with dementia and newly diagnosed major depressive disorders (MDD).This retrospective cohort study included older adults (aged ≥65 years) with dementia and newly diagnosed MDD using Medicare 5% sample claims data (2012-2013). Based on Healthcare

2019 The American Journal of Geriatric Psychiatry

245. Culturally adapted depression education and engagement in treatment among Hispanics in primary care: outcomes from a pilot feasibility study. Full Text available with Trip Pro

health treatments. In 2014, the Center for Medicare and Medicaid Services (CMS) funded the Depression Screening and Education: Options to Reduce Barriers to Treatment (DESEO) project to implement an education intervention designed to increase disease literacy and dispel myths about depression and its treatment among Hispanic patients thus reducing stigma and increasing treatment engagement.The DESEO study utilized a one-group pretest-posttest design to assess the effects a culturally-adapted (...) Depression Education Intervention's (DEI) on depression knowledge, stigma, and engagement in treatment in a sample of 350 Hispanic primary care patients with depression. The DEI utilized a fotonovela, a health education tool available in English and Spanish that uses posed photographs, captions, and soap opera narratives to raise awareness about depression and depression treatments.Participants reported significant decreases in depression symptoms and reported stigma about mental health care

2019 BMC Family Practice

246. Prostate Cancer Screening (PDQ®): Health Professional Version

risk.[ ] Not all studies, however, have confirmed this association.[ ] Screening by Serum PSA The PSA test has been examined in several observational settings for initial diagnosis of disease, as a tool in monitoring for recurrence after initial therapy, and for prognosis of outcomes after therapy. Numerous studies have also assessed its value as a screening intervention for the early detection of prostate cancer. Potential value of the test appears to be its simplicity, objectivity (...) Prostate Cancer Screening (PDQ®): Health Professional Version Prostate Cancer Screening (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf Warning: The NCBI web site requires JavaScript to function. Search database Search term Search NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health. PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-. PDQ Cancer Information Summaries [Internet]. Bethesda (MD

2018 PDQ - NCI's Comprehensive Cancer Database

247. Comparing the feasibility, acceptability, clinical-, and cost-effectiveness of mental health e-screening to paper-based screening on the detection of depression, anxiety, and psychosocial risk in pregnant women: a study protocol of a randomized, parallel- Full Text available with Trip Pro

. Secondary objectives are to compare the two modes of screening on: (1) the level of detection of prenatal depression and anxiety symptoms and psychosocial risk; (2) the level of disclosure of symptoms; (3) the factors associated with feasibility, acceptability, and disclosure; (4) the psychometric properties of the e-version of the assessment tools; and (5) cost-effectiveness. A sample of 542 women will be recruited from large, primary care maternity clinics and a high-risk antenatal unit in an urban (...) Comparing the feasibility, acceptability, clinical-, and cost-effectiveness of mental health e-screening to paper-based screening on the detection of depression, anxiety, and psychosocial risk in pregnant women: a study protocol of a randomized, parallel- Stress, depression, and anxiety affect 15% to 25% of pregnant women. However, substantial barriers to psychosocial assessment exist, resulting in less than 20% of prenatal care providers assessing and treating mental health problems. Moreover

2014 Trials Controlled trial quality: uncertain

248. What does it mean when we screen? A closer examination of perinatal depression and psychosocial risk screening within one MCH home visiting program Full Text available with Trip Pro

tools were inconsistent in identifying "at risk" women for perinatal depression, ranging from 22 % (Edinburgh Perinatal Depression Scale) to 75 % (Center for Epidemiological Studies, Depression Scale) depending on the instrument. Depression and anxiety were correlated across most measures, although provider-collected data did not correlate as anticipated with other measures. The combination of screening for perinatal depression and stressful life events offered an additional perspective on possible (...) What does it mean when we screen? A closer examination of perinatal depression and psychosocial risk screening within one MCH home visiting program Perinatal depression screening has become an imperative for maternal and child health (MCH) home visitation programs. However, contextual life experiences and situational life stress may be equally important in determining program response. As one component of a larger research study with an urban MCH home visitation program, we examined the results

2014 Maternal and child health journal

249. An online healthy relationship tool and safety decision aid for women experiencing intimate partner violence (I-DECIDE): a randomised controlled trial. Full Text available with Trip Pro

An online healthy relationship tool and safety decision aid for women experiencing intimate partner violence (I-DECIDE): a randomised controlled trial. Evidence for online interventions to help women experiencing intimate partner violence is scarce. We assessed whether an online interactive healthy relationship tool and safety decision aid (I-DECIDE) would increase women's self-efficacy and improve depressive symptoms compared with an intimate partner violence information website.In this two (...) -group pragmatic randomised controlled trial, we enrolled women who had screened positive for any form of intimate partner violence or fear of a partner in the 6 months before recruitment. Women aged 16-50 years currently residing in Australia, who had safe access to a computer and an internet connection, and who answered positively to one of the screening questions in English were eligible for inclusion. Participants were randomly assigned (1:1) by computer to receive either the intervention

2019 The Lancet. Public health Controlled trial quality: predicted high

250. Headlines raise alarm over prescription drug depression risk. But who qualifies as depressed?

important things to bear in mind. First, this is self-reported by patients. And that’s notoriously difficult to replicate. Furthermore, suggests that psychiatric studies which rely upon such questionnaires tend to OVERestimate the prevalence; most likely because the questionnaires set a very low (ie. overinclusive) bar, and patients have difficulty recalling the duration and severity of their symptoms. Second, the tool is designed to screen for depression, NOT diagnose it. (A positive result is intended (...) Headlines raise alarm over prescription drug depression risk. But who qualifies as depressed? Headlines raise alarm over prescription drug depression risk. But who qualifies as depressed? - HealthNewsReview.org Note to our followers: Our nearly 13-year run of daily publication of new content on HealthNewsReview.org came to a close at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. But all of the 6,000+ articles we have published contain

2018 HealthNewsReview

251. Diet and depression: can we eat our way out of clinical depression? The ‘SMILES’ trial

Screening Tool (DST) to confirm ‘poor’ dietary quality (low usual consumption of dietary fibre, lean proteins and fruit and vegetables, and a high intake of sweets, processed meats and salty snacks) Antidepressants or psychotherapy were allowed if stable ≥2 weeks. Exclusion criteria Bipolar disorder Personality disorder Treatment resistant depression Severe food allergies/aversions Interventions Dietary support (ModiMedDiet) comprised of seven 60-minute sessions of personalised dietary advice (...) Diet and depression: can we eat our way out of clinical depression? The ‘SMILES’ trial Diet and depression: can we eat our way out of clinical depression? Search National Elf Service Search National Elf Service » » » » Diet and depression: can we eat our way out of clinical depression? The ‘SMILES’ trial Mar 27 2017 Posted by The link between diet and depression is not novel. Although there is no standardised definition of a ‘healthy diet’, diets based on vegetables and lean fish seem

2017 The Mental Elf

252. Depression (PDQ®): Health Professional Version

diagnoses at follow-up.[ ] Heightened awareness of this facilitates early diagnosis and the use of appropriate interventions.[ ] In the medically ill, early manifestations of delirium may be mistaken for anxiety or depression. These disorders should be considered among the differential diagnoses in individuals who present with depressive symptoms. Screening and Assessment for Depression Because of the common underrecognition and undertreatment of depression in people with cancer, screening tools can (...) be used to prompt further assessment.[ ] Among the physically ill, in general, instruments used to measure depression have not been shown to be more clinically useful than an interview and a thorough examination of mental status. Simply asking the patient whether he or she is depressed may improve the identification of depression. The following screening tools are commonly used: A single-item interview. In persons with advanced cancer, a single-item interview question has been found to have acceptable

2017 PDQ - NCI's Comprehensive Cancer Database

253. Ketamine for treatment-resistant depression: recent developments and clinical applicationsEditor's Choice FREE Full Text available with Trip Pro

the glutamate receptor, which still needs to be further understood in humans in order to potentially develop screening procedures for appropriately prescribing of ketamine. In conclusion, a critical number of studies support the efficacy of ketamine as a rapidly acting treatment for patients with TRD, while some studies also suggest efficacy in bipolar depression, PTSD and in those with acute SI. At this point, clinicians and patients should be aware of the limited information available regarding optimal (...) dosing and long-term effects of ketamine treatment. We remain, however, cautiously optimistic and believe that ketamine has the potential to become a very important tool in the clinical treatment of severe mood and anxiety disorders ( ). View this table: Table 1 Summary of clinical perspectives on ketamine administrations for treatment-resistant mood disorders References Marcus M , Yasamy MT , van , et al . Depression: a global public health concern . WHO Department of Mental Health and Substance

2016 Evidence-Based Mental Health

254. The effects of psychotherapy on reducing depression in residential aged care: a meta-analytic review

, for articles in English. Unpublished data were sought from ProQuest. Search terms were reported. Reference lists of relevant studies were manually screened. Study selection Eligible for inclusion were randomised controlled trials (RCTs) assessing the efficacy of psychotherapy (as defined in the review), for the treatment of depressive symptoms or disorders, for patients in residential care for the elderly (including assisted living and long-term care). Participants were eligible if they were aged over 50 (...) on a waiting list, or received an alternative active intervention, such as social discussion. Some participants were on psychotropic medication. Their cognitive status was measured using various tools. The authors did not state how many reviewers screened studies for inclusion. Assessment of study quality The trial methods were assessed using the Cochrane risk of bias tool and the 23-item Quality Rating Scale; a score of more than 25 out of 46 on the Quality Rating Scale indicated high quality. The authors

2013 DARE.

255. Vision screening of older drivers for preventing road traffic injuries and fatalities. (Abstract)

. Although there is a clear need to develop evidence-based and validated tools for vision screening for driving, the effectiveness of existing vision screening tools remains unclear. This represents an important and highly warranted initiative to increase road safety worldwide.To assess the effects of vision screening interventions for older drivers to prevent road traffic injuries and fatalities.For the update of this review we searched the Cochrane Injuries Group's Specialised Register, the Cochrane (...) studies to assess the effects of vision screening tests on subsequent motor vehicle crash reduction. There is a need to develop valid and reliable tools of vision screening that can predict driving performance.

2014 Cochrane

256. What are the recommended clinical assessment and screening tests during pregnancy?

What are the recommended clinical assessment and screening tests during pregnancy? 2015 www.kce.fgov.be KCE REPORT 248Cs SYNTHESIS WHAT ARE THE RECOMMENDED CLINICAL ASSESSMENT AND SCREENING TESTS DURING PREGNANCY? 2015 www.kce.fgov.be KCE REPORT 248Cs GOOD CLINICAL PRACTICE SYNTHESIS WHAT ARE THE RECOMMENDED CLINICAL ASSESSMENT AND SCREENING TESTS DURING PREGNANCY? WILFRIED GYSELAERS, PASCALE JONCKHEER, NADERA AHMADZAI, MOHAMMED T. ANSARI, SERENA CARVILLE, KATHARINA DWORZYNSKI, LAURA GAUDET (...) , JESSICA GLEN, KATIE JONES, PAUL MILLER, JENNIFER MARIE TETZLAFF, SOPHIE ALEXANDER, KAREL ALLEGAERT, KATRIEN BEECKMAN, GILLES CEYSENS, YOLANDE CHRISTIANE, NADINE DE RONNE, BÉNÉDICTE DE THYSEBAERT, NICOLE DEKKER, ALEXANDRA DENYS, PATRICIA EECKELEERS, ANA HERNANDEZ, EVELYNE MATHIEU, LIEVE SEUNTJENS, LEEN VERLEYE, SABINE STORDEUR KCE Report 248Cs Assessment and screening during pregnancy 1 ¦ FOREWORD Pregnancy usually is quite a joyful experience … of a very natural physiological happening

2015 Belgian Health Care Knowledge Centre

257. Validation of Self-Management Screening (SeMaS), a tool to facilitate personalised counselling and support of patients with chronic diseases. Full Text available with Trip Pro

care.We drafted a prototype of the tool for Self-Management Screening (SeMaS), comprising 27 questions that were mainly derived from validated questionnaires. To reach high content validity, we performed a literature review and held focus groups with patients and healthcare professionals as input for the tool. The characteristics self-efficacy, locus of control, depression, anxiety, coping, social support, and perceived burden of disease were incorporated into the tool. Three items were added to guide (...) Validation of Self-Management Screening (SeMaS), a tool to facilitate personalised counselling and support of patients with chronic diseases. A rising number of people with chronic conditions is offered interventions to enhance self-management. The responsiveness of individuals to these interventions depends on patient characteristics. We aimed to develop and validate a tool to facilitate personalised counselling and support for self-management in patients with chronic diseases in primary

2015 BMC Family Practice

258. A prospective study of suicide screening tools and their association with near-term adverse events in the ED. (Abstract)

A prospective study of suicide screening tools and their association with near-term adverse events in the ED. The goal of this study was to evaluate the relationship between various suicide screening tools and clinical impression with subsequent patient psychiatric admission and near-term adverse emergency department (ED) events.We performed a prospective observational study of 50 patients with suicidal ideation in the ED. Subjects completed a series of depression/suicide screening tools (...) of .05 level, no screening tools correlated with patient ED course or likelihood of psychiatric admission.Clinical impression alone and the suicide screening tools showed poor predictive value for near-term events. Data from this study highlight the need for the development of ED-based suicide screening instruments capable of identifying those patients with suicidal ideation at greatest risk.Copyright © 2015 Elsevier Inc. All rights reserved.

2015 American Journal of Emergency Medicine

259. Optimising screening for cognitive dysfunction in bipolar disorder: Validation and evaluation of objective and subjective tools. (Abstract)

Optimising screening for cognitive dysfunction in bipolar disorder: Validation and evaluation of objective and subjective tools. Cognitive impairment is common in bipolar disorder and contributes to socio-occupational difficulties. The objective was to validate and evaluate instruments to screen for and monitor cognitive impairments, and improve the understanding of the association between cognitive measures and socio-occupational capacity.Patients with bipolar disorder in partial or full (...) remission (n=84) and healthy controls (n=68) were assessed with the Screen for Cognitive Impairment in Psychiatry (SCIP), Cognitive Complaints in Bipolar Disorder Rating Scale (COBRA), and established neuropsychological tests and subjective rating scales. Socio-occupational function and affective symptoms were evaluated with the Functional Assessment Short Test, and the Hamilton Depression Rating Scale 17-items and Young Mania Rating Scale, respectively. Concurrent validity of the SCIP and COBRA were

2015 Journal of Affective Disorders

260. Checking Out Checking In: The Development and Validation of an Electronic Screening Tool for Pediatric Psychosocial Distress

Checking Out Checking In: The Development and Validation of an Electronic Screening Tool for Pediatric Psychosocial Distress Checking Out Checking In: The Development and Validation of an Electronic Screening Tool for Pediatric Psychosocial Distress - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached (...) the maximum number of saved studies (100). Please remove one or more studies before adding more. Checking Out Checking In: The Development and Validation of an Electronic Screening Tool for Pediatric Psychosocial Distress The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our

2015 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>